Universal-Beteiligungs- und Servicegesellschaft
RXRX icon

Universal-Beteiligungs- und Servicegesellschaft’s Recursion Pharmaceuticals RXRX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$946K Buy
257,658
+29,995
+13% +$99.9K ﹤0.01% 1589
2026
Q1 		$699K Sell
227,663
-4,707
-2% -$18.2K ﹤0.01% 1624
2025
Q4 		$954K Buy
232,370
+2,753
+1% +$13.6K ﹤0.01% 1508
2025
Q3 		$1.12M Buy
+229,617
New +$1.21M ﹤0.01% 1509
2025
Q2 		– Sell
-10,829
Closed -$57.3K – 2096
2025
Q1 		$57.3K Buy
+10,829
New +$78.9K ﹤0.01% 1968

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's RXRX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Recursion Pharmaceuticals (RXRX) stake by 13% in Q2 2026, buying an estimated $99.9K and bringing the position to 257,658 shares worth $946K. The position accounts for ﹤0.01% of the portfolio, ranked #1589.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in RXRX in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.12M in Q3 2025. 205 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 257,658 shares of Recursion Pharmaceuticals worth $946K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 29,995 Recursion Pharmaceuticals shares in Q2 2026, an estimated $99.9K.
  • Recursion Pharmaceuticals made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1589 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Recursion Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Recursion Pharmaceuticals position peaked at $1.12M in Q3 2025.
  • 205 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.